• Europe
    • Menu
    Disease

    Field trial proves vaccine against edema disease is safe and efficacious

    A multicenter, randomised field trial tested the efficacy and safety of VEPURED®, a new vaccine against Edema disease in pigs.
    calendar icon 10 June 2019
    clock icon 8 minute read
    By: Eva Perozo | Joaquim Mallorqui
    Europe
    Table showing outbreak of ED in 5 farms, population sized and whether they were treated or received a placebo
    Table 1. Demographic details and clinical characteristics for each group.
    Table 2. PCR primers used to amplify F18 and Vt2e genes of E.coli in this study.
    Table 2. PCR primers used to amplify F18 and Vt2e genes of E.coli in this study.
    Table Summary of faecal and intestinal samples analysed by bacteriological diagnosis
    Table 3. Summary of faecal and intestinal samples analysed by bacteriological diagnosis.
    Table 4. Mortality attributed to edema Disease.
    Table 4. Mortality attributed to edema Disease.
    Table 5. Summary of animals showing edema disease clinical signs
    Table 5. Summary of animals showing edema disease clinical signs
    Table 6. Evolution of animal weights in farms with clinical Edema Disease (Mean ± SD).
    Table 6. Evolution of animal weights in farms with clinical Edema Disease (Mean ± SD).
    References
    References
    [1] Fairbrother J. M. and Gyles C.
    (2012) Disease of swine, 10th. eds. Zimmerman J. J., Karriker L. A., Ramirez A., Schwartz K. J. and Stevenson G. W. Ames, Iowa. Chap 53 (Colibacilosis), 723-749.
    [2] Casanova N. A., Redondo L. M., Dailoff G. C., Arenas D. and Fernández Miyakawa M. E.
    (2018) Overview of the role of Shiga toxins in porcine edema disease pathogenesis. Toxicon. 15: 148154.
    [3] Bergan J., Dyve Lingelem A. B., Simm R., Skotland T. and Sandwig K
    (2012) Shiga toxins. Toxicon, 60(6): 1085-1107.
    [4] Clugston R. E., Nielsen N. O. and Smith D. L. T.
    (1974) Experimental edema disease of swine (E. coli enterotoxemia) III. Pathology and pathogenesis. Can J Comp Med, 38: 34-43.
    [5] MacLeod D. L., Gyles C. L. and Wilcock B. P.
    (1991) Reproduction of oedema disease of swine with purified Shiga-like toxin-II variant. Vet Pathol, 28: 66–73.
    [6] Bosworth B. T., Samuel J. E., Moon H. W., O'brien A. D., Gordon V. M. and Whipp S. C.
    (1996) Vaccination with genetically modified Shiga-like toxin IIe prevents oedema disease in swine. Infect Immun, 64: 55-60.
    [7] Bosworth B. T., Green R. A. and Morrison R. B.
    (1994) Oedema disease: A search for a genetic link. J Swine Health Prod, 2(3): 1922.
    [8] Teuber M.
    (2001) Veterinary use and antibiotic resistence. Curr Opin Microbiol, 4: 493-499
    [9] Phillips I., Casewell M., Cox T., de Groot B., Friis C., Jones R., Nightingale C., Preston R. and Waddell J.
    (2004) Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob Chemother, 53: 28-52.
    [10] Kusumoto M., Hidoka Y., Fujii Y., Murata M., Miyoshi H., Ogura Y., Gotoh Y., Iwata T., Hayashi T. and Akiba M.
    (2016) Emergence of a Multidrug-Resistant Shiga Toxin-Producing Enterotoxigenic Escherichia coli Lineage in Diseased Swine in Japan. J Clin Microbiol, 54(4): 1074-1081.
    [11] Bednorz C., Oelgeschläger K., Kinnemann B., Hartmann S., Neumann K., Pieper R., et al.
    (2013) The broader context of antibiotic resistance: zinc feed supplementation of piglets increases the proportion of multi-resistant Escherichia coli in vivo. Intl J Medical Microbiol. 303: 396–403.
    [12] Won G., John Hwa L.
    (2017) Potent immune responses induced by a Salmonella ghost delivery system that expresses the recombinant Stx2eB, FedF, and FedA proteins of the Escherichia coli-producing F18 and Shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate. Vet Q. 37(1): 8190.
    [13] Toshio S., Takeshi M., Eiji T., Yumiko K., Sou-Ichi M., Ko K., Kazutoshi S. and Takashi H.
    (2013) Evaluation of Recombinant Forms of the Shiga Toxin Variant Stx2eB Subunit and Non-Toxic Mutant Stx2e as Vaccine Candidates against Porcine Edema Disease. J Vet Med Sci. 75(10): 1309–1315.
    [14] Oanh T. K., Nguyen V. K., de Greve H. and Goddeeris B. M.
    (2012) Oanh T. K., Nguyen V. K., de Greve H. and Goddeeris B. M.
    [15] European Medicines Agency.
    (2013) CVMP assessment report for ECOPORC SHIGA. Retrieved 04/12/2018 from
    [16] European Medicines Agency.
    (2017) CVMP assessment report for VEPURED.
    [17] Mallorquí J., Simon-Grifé M., Ferrer-Soler L., Roca M., March R. and Sitjà M.
    (2018) Reduced mortality and morbidity associated with verotoxin 2e-induced edema disease in pigs using a recombinant verotoxin 2e vaccine. J. Swine Health Prod. 26(5): 253-261.
    [18] U.S. Department of Health and Human Services, Center for veterinary Medicine.
    (2001) Guidance for industry: Good Clinical Practives.
    [19] Zhang W., Zhao M., Ruesch L., Omot A. and Francis D.
    (2007) Prevalence of virulence genes in Escherichia coli strains recently isolated from young pigs with diarrhoea in the US. Vet Microbiol, 123: 145-152.
    [20] Badiella L. and Marino A. P.
    (2005) Cálculo del tamaño muestral ™ con el programa Ene 2.0: manual del programa, documentación y ejemplos. eds. Gráficas Monterreina. Spain, Madrid.
    [21] Johansen M., Andresen L. O., Jorsal S. E., Thomsen L. K., Waddell T. E. and Gyles C. L.
    (1997) Prevention of oedema disease in pigs by vaccination with verotoxin 2e toxoid. Can J Vet Res, 61: 280285.
    [22] Fricke R., Bastert O., Gotter V., Brons N., Kamp J. and Selbitz H. J.
    (2015) Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study. Porcine Health Management, 1: 6.
    [23] Gordon N. A., Whipp S. C., Moon H. W., O'Brien A. D. and Samuels J. E.
    (1992) An enzymatic mutant of Shiga-like toxin-II variant is a vaccine candidate for oedema disease of swine. Infect Immun, 60: 485-490.
    [24] Makino S. I., Watarai M., Tabuchi H., Shirahata T., Furuoka H., Kobayashi Y. and Takeda Y.
    (2001) Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine oedema disease. Microb Pathog, 31: 1– 8.
    [25] Gannon V. P., Gyles C. L. and Wilcock B. P.
    (1989) Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs. Can J Vet Res, 53: 306-312.

    Sponsored Article

    Hipra

    Our Partners

    Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive

    Eva Perozo

    Hipra
    More from this author

    Joaquim Mallorqui

    Hipra
    More from this author

    More Articles

    View all

    Leman Swine Conference: Controlling PEDV with bioexclusion, biocontainment and biomanagement

    Disease Managing disease Herd management
    calendar icon 24 April 2024
    clock icon 5 minute read

    AASV: Paul Yeske shares research on how to use soybean meal during a swine respiratory challenge

    Disease Notifiable diseases PRRS
    calendar icon 23 April 2024
    clock icon 7 minute read
    Soybean meal as a tactical or prescriptive ingredient when SRD challenges the herd

    Speed matters: Fast protein sources result in better protein utilization

    Herd management Feed and nutrition
    calendar icon 22 April 2024
    clock icon 6 minute read
    Protein kinetics is all about the speed of protein digestion.

    Sponsored Article

    Hipra

    Our Partners

    Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive
    No Advert Set
    © 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.
  • Our Sites